According to WiseGuy Reports, the Myristoyl Pentapeptide 17 Market was valued at USD 300 million in 2024 and maintained a market size of USD 300 million in 2025. The market is forecast to reach USD 500 million by 2035, registering a CAGR of 5.9% during the forecast period. Increasing demand for advanced skincare solutions, rising consumer focus on anti-aging products, growing cosmetic innovation, expansion of digital beauty platforms, and increasing applications in hair care products are driving market development. Leading companies including Innospec, Dow Chemical, Mibelle Group, Ashland, Sederma, Lonza Group, Croda International, Evonik Industries, BASF, and Givaudan are investing in research, ingredient innovation, and strategic collaborations to strengthen their global market presence.

Market Overview

The Myristoyl Pentapeptide 17 Market represents an emerging segment within the cosmetic ingredients industry, driven by increasing interest in peptide-based skincare and personal care solutions. Myristoyl Pentapeptide 17 is a synthetic peptide ingredient commonly used in beauty formulations due to its functional properties and compatibility with various cosmetic products.

The ingredient is increasingly incorporated into anti-aging products, facial serums, creams, lotions, and specialized hair care formulations. Cosmetic manufacturers are utilizing advanced peptides to create premium products that address consumer expectations for effective and scientifically developed skincare solutions.

Growing awareness regarding active cosmetic ingredients has encouraged brands to invest in innovative formulations. The rising popularity of professional-grade skincare products among individual consumers and beauty enthusiasts continues to create new opportunities for ingredient suppliers.

Market Size

The Myristoyl Pentapeptide 17 Market reached USD 300 million in 2025 after maintaining a market value of USD 300 million in 2024. Increasing adoption among cosmetic manufacturers and expanding demand for functional beauty products have supported market stability.

The market is projected to reach USD 500 million by 2035, supported by rising investments in cosmetic research, increasing consumer spending on premium skincare products, and broader applications across beauty and dermatology sectors.

The expansion of online retail channels has further contributed to market accessibility by enabling consumers to purchase specialized cosmetic products from global brands.

Growth Opportunities

The growing anti-aging skincare segment presents significant opportunities for Myristoyl Pentapeptide 17 suppliers. Aging populations, increasing skincare awareness, and consumer interest in preventive beauty solutions are encouraging manufacturers to develop advanced formulations containing active peptides.

The cosmetic industry's continuous focus on innovation provides additional growth potential. Brands are launching multifunctional products combining moisturizing, rejuvenating, and skin-enhancing properties to attract consumers seeking comprehensive skincare solutions.

Hair care applications represent another promising opportunity. Increasing interest in products designed to support healthier-looking hair has encouraged manufacturers to explore peptide-based ingredients beyond traditional skincare categories.

Expansion into emerging markets is also expected to create new growth opportunities as rising disposable incomes and changing beauty preferences increase demand for premium personal care products.

Regional Analysis

North America represents a significant market for Myristoyl Pentapeptide 17 due to strong consumer demand for advanced skincare products and the presence of established cosmetic brands. High spending on premium beauty products and increasing interest in innovative ingredients continue supporting regional growth.

Europe maintains an important position due to its developed cosmetics industry and strong emphasis on product quality, safety standards, and research-based formulations. The region’s focus on advanced personal care solutions encourages the adoption of specialized peptide ingredients.

Asia-Pacific is expected to witness strong growth during the forecast period due to expanding beauty markets in countries such as China, India, Japan, and South Korea. Rising consumer awareness, increasing e-commerce adoption, and growing demand for skincare products are driving regional opportunities.

South America and the Middle East & Africa are gradually developing as emerging markets as cosmetic consumption increases and international beauty brands expand their presence.

Recent Industry Developments

Companies operating in the Myristoyl Pentapeptide 17 Market are focusing on research and development activities to improve ingredient performance and expand application areas. Manufacturers are introducing innovative peptide solutions designed for modern cosmetic formulations.

Strategic partnerships between ingredient suppliers and cosmetic manufacturers are becoming increasingly common as companies seek to accelerate product development and improve market reach.

The adoption of advanced formulation technologies is helping brands create more effective skincare products with improved stability, texture, and consumer appeal.

Digital transformation within the beauty industry has also influenced product marketing and distribution strategies. Online platforms are enabling companies to reach global customers while increasing awareness of specialized skincare ingredients.

Market Challenges

The Myristoyl Pentapeptide 17 Market faces several challenges, including regulatory requirements associated with cosmetic ingredients and variations in approval standards across different regions. Manufacturers must comply with safety regulations while maintaining product innovation.

High research and development costs related to peptide formulation may also affect smaller market participants. Developing effective cosmetic ingredients requires continuous investment in scientific research and testing.

Competition from alternative active ingredients presents another challenge as cosmetic brands evaluate multiple solutions to achieve desired skincare benefits. Companies must continue improving product performance and differentiation to maintain market competitiveness.

Fluctuations in raw material availability and production costs may also influence pricing strategies within the industry.

Competitive Landscape

The Myristoyl Pentapeptide 17 Market is characterized by competition among global specialty ingredient manufacturers, biotechnology companies, and cosmetic solution providers. Market participants are focusing on innovation, partnerships, and portfolio expansion to strengthen their positions.

Key companies operating in the market include Innospec, Dow Chemical, Mibelle Group, Happi, Ashland, Sederma, AkzoNobel, SABIC, Lonza Group, Sytheon, Rudolf GmbH, Croda International, Evonik Industries, BASF, and Givaudan.

These organizations are investing in advanced peptide research, expanding cosmetic ingredient offerings, and developing solutions for skincare, dermatology, and hair care applications.

The Myristoyl Pentapeptide 17 Market is expected to experience consistent growth through 2035 as consumer demand for innovative beauty products, anti-aging solutions, and advanced cosmetic formulations continues increasing. Ongoing research, expanding applications, and global cosmetic industry growth will remain key factors shaping the market’s future development.